Thorgeir E Thorgeirsson

Title: Thorgeir E Thorgeirsson: Innovator in Genetic Research

Introduction

Thorgeir E Thorgeirsson is a prominent inventor based in Reykjavik, Iceland. He has made significant contributions to the field of genetic research, particularly in understanding susceptibility variants for various diseases. With a total of two patents to his name, Thorgeirsson's work has the potential to impact risk assessment and management in healthcare.

Latest Patents

Thorgeirsson's latest patents include groundbreaking inventions related to genetic variants associated with serious health conditions. The first patent focuses on susceptibility variants for lung cancer. This invention discloses certain genetic variants that serve as susceptibility markers for lung cancer. It also relates to methods of risk assessment using these variants and includes kits designed for risk assessment of lung cancer. The second patent addresses susceptibility variants for peripheral arterial disease (PAD) and abdominal aortic aneurysm (AAA). This invention reveals specific genetic variants that indicate susceptibility to PAD and AAA, along with methods for risk management and kits for risk assessment.

Career Highlights

Thorgeirsson is affiliated with Decode Genetics Ehf, a company known for its innovative research in genetics. His work at Decode Genetics has allowed him to explore the genetic underpinnings of various diseases, contributing to advancements in personalized medicine and risk assessment.

Collaborations

Thorgeirsson has collaborated with notable colleagues in his field, including Patrick Sulem and Frank Geller. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Thorgeir E Thorgeirsson is a distinguished inventor whose work in genetic research has led to significant advancements in understanding disease susceptibility. His patents not only contribute to scientific knowledge but also hold promise for improving healthcare outcomes.